Patients with severe keratitis in dry eye disease experienced statistically significant reductions in corneal fluorescein staining scores after treatment with cyclosporine, according to 3-month data from the PERSPECTIVE study.
Santen presented the study data at the European Society of Ophthalmology congress. The ongoing, non-interventional prospective study evaluated the effectiveness, tolerability and safety of cyclosporine for the treatment of severe keratitis in patients with dry eye disease who failed to respond to previous artificial tear treatments.
The 3-month data showed statistically
Uncategorized